Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12188/17701
Title: | The importance of routinely reporting non-HDL cholesterol by the clinical laboratory | Authors: | Tosheska Trajkovska, Katerina Kostovska, Irena Bosilkova, Gordana |
Keywords: | non HDL cholesterol blood lipids predictor heart disease laboratory report |
Issue Date: | 2017 | Publisher: | BioMed Central Ltd. | Journal: | EPMA Journal | Conference: | EPMA World Congress 2017, Malta | Abstract: | Background. It is well known that a standard lipid profile measures total cholesterol, triglycerides, and HDL cholesterol (HDL-c), while LDL cholesterol is estimated. Subtracting HDL-c from total cholesterol, we can measure the amount of cholesterol carried by all lipoproteins except HDL. This simple math will give the amount of non-HDL cholesterol (non-HDL-c) within all atherogenic lipoproteins. However, although it is so easy, biochemical laboratories rarely report the value of non-HDL-c. Aim of the study. The aim of our study is to highlight the results of several studies that clearly establish the clinical use of non–HDL cholesterol as a common predictor of blood lipid patterns associated with increased risk of heart disease. Material. Recent literary evidence and clinical studies. Results. The most important document regarding non-HDL-c was delivered by the National Cholesterol Education Program Adult Treatment Panel III, where non–HDL-c was highlighted as a key secondary goal of therapy in lipid treatment and lipoprotein management. Other studies suggest that non-HDL-c shows a better correlation with small dense LDL particles than do other lipid parameters, including LDL-c. The treatment goal for non-HDL-c is usually 30 mg/dL above the LDL-c treatment target. Conclusion. Knowing that non–HDL-c is superior to LDL-c for the prediction of cardiovascular events, it is very important for each clinical chemistry laboratory to report non–HDL-c as a part of routine lipid status, with no added expense. Doctors could use it for optimal prevention of atherosclerosis and cardiovascular disease. | URI: | http://hdl.handle.net/20.500.12188/17701 | DOI: | 10.1007/s13167-017-0108-4 |
Appears in Collections: | Faculty of Medicine: Conference papers |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
2017_Article_EPMAWorldCongress (1).pdf | 8.94 MB | Adobe PDF | View/Open |
Page view(s)
65
checked on Sep 13, 2024
Download(s)
14
checked on Sep 13, 2024
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.